Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders
عرض / فتح
التاريخ
2020-11-09المؤلف
Dakroub, AliA Nasser, Suzanne
Younis, Nour
Bhagani, Humna
Al-Dhaheri, Yusra
Pintus, Gianfranco
Eid, Assaad A.
El-Yazbi, Ahmed F.
Eid, Ali H.
...show more authors ...show less authors
البيانات الوصفية
عرض كامل للتسجيلةالملخص
Visfatin/NAMPT (nicotinamide phosphoribosyltransferase) is an adipocytokine with several intriguing properties. It was first identified as pre-B-cell colony-enhancing factor but turned out to possess enzymatic functions in nicotinamide adenine dinucleotide biosynthesis, with ubiquitous expression in skeletal muscles, liver, cardiomyocytes, and brain cells. Visfatin exists in an intracellular (iNAMPT) and extracellular (eNAMPT) form. Intracellularly, visfatin/iNAMPT plays a regulatory role in NAD+ biosynthesis and thereby affects many NAD-dependent proteins such as sirtuins, PARPs, MARTs and CD38/157. Extracellularly, visfatin is associated with many hormone-like signaling pathways and activates some intracellular signaling cascades. Importantly, eNAMPT has been associated with several metabolic disorders including obesity and type 1 and 2 diabetes. In this review, a brief overview about visfatin is presented with special emphasis on its relevance to metabolic diseases. Visfatin/NAMPT appears to be a unique molecule with clinical significance with a prospective promising diagnostic, prognostic, and therapeutic applications in many cardiovasculo-metabolic disorders.
معرّف المصادر الموحد
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096083087&origin=inwardالمجموعات
- أبحاث الطب [1509 items ]
- أبحاث الصيدلة [1314 items ]